BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7467311)

  • 1. Prescribing narcotics to habitual and addicted narcotic users. Medical and legal guidelines in California and some other Western states.
    Tennant FS; Uelmen GF
    West J Med; 1980 Dec; 133(6):539-45. PubMed ID: 7467311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regular prescription of narcotics and sedatives to drug-addicted patients in general practice].
    Andersen HT
    Tidsskr Nor Laegeforen; 2002 May; 122(12):1202-4. PubMed ID: 12089847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Political and legal aspects of pharmacist prescribing.
    Stimmel GL
    Am J Hosp Pharm; 1983 Aug; 40(8):1343-4. PubMed ID: 6614020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone therapy for opioid dependence.
    Krambeer LL; von McKnelly W; Gabrielli WF; Penick EC
    Am Fam Physician; 2001 Jun; 63(12):2404-10. PubMed ID: 11430455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. User views on supervised methadone consumption.
    Stone E; Fletcher K
    Addict Biol; 2003 Mar; 8(1):45-8. PubMed ID: 12745415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using buprenorphine for outpatient opioid detoxification.
    Manlandro JJ
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
    Turner BJ; Laine C; Lin YT; Lynch K
    Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The California registration system for habitues to schedule II drugs.
    Tennant FS
    NIDA Res Monogr; 1981 Feb; 34():193-8. PubMed ID: 6783931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New guidelines against unfair treatment of narcotic addicts necessary].
    Heilig M; Gunne L
    Lakartidningen; 2008 Oct 29-Nov 4; 105(44):3093-4. PubMed ID: 19031975
    [No Abstract]   [Full Text] [Related]  

  • 11. Buprenorphine for office-based treatment of patients with opioid addiction.
    Manlandro JJ
    J Am Osteopath Assoc; 2005 Jun; 105(6 Suppl 3):S8-13. PubMed ID: 16118361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone treatment in Ontario after the 1996 regulation reforms. Results of a physician survey.
    Fischer B; Cape D; Daniel N; Gliksman L
    Ann Med Interne (Paris); 2002 Nov; 153(7 Suppl):2S11-21. PubMed ID: 12518078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing to drug misusers in practice--often effective, but rarely straightforward.
    Seivewright N; Iqbal MZ
    Addict Biol; 2002 Jul; 7(3):269-77. PubMed ID: 12126485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician supply and medical education in California. A comparison with national trends.
    Grumbach K; Coffman JM; Young JQ; Vranizan K; Blick N
    West J Med; 1998 May; 168(5):412-21. PubMed ID: 9614798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus statement on office-based treatment of opioid dependence using buprenorphine.
    Fiellin DA; Kleber H; Trumble-Hejduk JG; McLellan AT; Kosten TR
    J Subst Abuse Treat; 2004 Sep; 27(2):153-9. PubMed ID: 15450648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of enforcement controlled substance laws in health policy for prescribing opiate medications: a painful assessment of morbidity and mortality.
    Miller NS
    Am J Ther; 2006; 13(6):527-33. PubMed ID: 17122534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance treatment. When and how to refer patients.
    DeMaria PA; Weinstein SP
    Postgrad Med; 1995 Mar; 97(3):83-6, 91-2. PubMed ID: 7877931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.